BioCryst Pharmaceuticals Inc. Comparables

Find the most relevant public market comparables for BioCryst Pharmaceuticals Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.

Company Overview

BioCryst Pharmaceuticals Inc. is a biotechnology company that designs, optimizes, and develops small molecule drugs to block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema.

Business Model

Research and development of novel small-molecule drugs targeting key enzymes involved in infectious and inflammatory diseases. Commercialization of approved drugs.

Target Customers

Patients with rare diseases, particularly hereditary angioedema (HAE), and those with influenza.

Specific Focus

Development of oral drugs for rare and serious diseases, with a focus on hereditary angioedema and antiviral therapies.

Location

Durham, North Carolina

CEO

Jon P. Stonehouse

Industry

Life sciences

Sub Sector

Pharmaceuticals

3yr Revenue Growth

1,761%

Public Market Comparables

Below are the key valuation metrics for companies similar to BioCryst Pharmaceuticals Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.

Looking for a comprehensive compset for BioCryst Pharmaceuticals Inc.? Our platform provides detailed analysis of BioCryst Pharmaceuticals Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full BioCryst Pharmaceuticals Inc. compset by trying our platform today.

EV/Revenue Multiple

Min

0.0x

Median

0.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details

EV/EBITDA Multiple

Min

00.0x

Median

00.0x

Max

00.0x

Unlock actual values by trying our platform

View Full Details
Screenshot of CompSetFinder showing BioCryst Pharmaceuticals Inc. comps with valuation metrics like EV/Revenue, EV/EBITDA, and P/E

Unlock the Full BioCryst Pharmaceuticals Inc. Compset

As a leading player in the Life sciences industry within the Biotechnology sector, BioCryst Pharmaceuticals Inc. operates in the specialized Pharmaceuticals sub-sector. Understanding how BioCryst Pharmaceuticals Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.

Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Pharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.

Get Your Custom Comparable Analysis

Need a more detailed analysis of BioCryst Pharmaceuticals Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.

Try CompsetFinder Free